CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 120 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $707,000 | -27.0% | 41,982 | -0.7% | 0.05% | -30.1% |
| Q1 2018 | $968,000 | -87.2% | 42,269 | -85.5% | 0.07% | -86.8% |
| Q4 2017 | $7,554,000 | +5579.7% | 292,010 | +2352.0% | 0.56% | +6066.7% |
| Q2 2016 | $133,000 | -52.7% | 11,909 | -42.2% | 0.01% | -52.6% |
| Q1 2016 | $281,000 | -90.0% | 20,600 | -86.2% | 0.02% | -90.6% |
| Q4 2015 | $2,823,000 | -36.4% | 148,835 | -37.1% | 0.20% | -35.6% |
| Q3 2015 | $4,439,000 | +192.6% | 236,517 | +107.7% | 0.32% | +211.9% |
| Q4 2014 | $1,517,000 | – | 113,894 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |